DBV Technologies (DBVT) EBT (2020 - 2026)
DBV Technologies (DBVT) reported EBT of -$47.4 million for Q1 2026, down 74.91% year-over-year from -$188.9 million in Q1 2025, and down 6.62% quarter-over-quarter from -$44.5 million in Q4 2025.
DBV Technologies (DBVT) EBT (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of EBT data on file, last reported at -$47.4 million in Q1 2026.
- EBT for Q1 2026 came in at -$47.4 million, down 74.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$166.8 million (down 46.73% YoY), and the FY2025 annual result was -$146.5 million, down 28.62% from the prior year.
- EBT eased to -$47.4 million in Q1 2026 per DBVT's latest filing, from -$44.5 million in the prior quarter.
- Over five years, EBT peaked at -$11.2 million in Q4 2023 and troughed at -$47.4 million in Q1 2026.
- A 5-year average of -$28.0 million and a median of -$27.1 million in 2025 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2023: EBT slumped 187.63% in 2022, then jumped 71.49% in 2023.
- A 5-year view of EBT shows it stood at -$39.3 million in 2022, then jumped by 71.49% to -$11.2 million in 2023, then sank by 105.58% to -$23.0 million in 2024, then tumbled by 93.22% to -$44.5 million in 2025, then retreated by 6.62% to -$47.4 million in 2026.
- Business Quant data shows DBVT's EBT at -$47.4 million in Q1 2026, -$44.5 million in Q4 2025, and -$33.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -47.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.40 Mn |
| Dec 31, 2025 | -44.46 Mn |
| Sep 30, 2025 | -33.16 Mn |
| Jun 30, 2025 | -41.76 Mn |
| Mar 31, 2025 | -27.10 Mn |
| Dec 31, 2024 | -23.01 Mn |
| Sep 30, 2024 | -30.44 Mn |
| Jun 30, 2024 | -33.12 Mn |
| Mar 31, 2024 | -27.30 Mn |
| Dec 31, 2023 | -11.19 Mn |
| Sep 30, 2023 | -16.74 Mn |
| Jun 30, 2023 | -24.23 Mn |
| Mar 31, 2023 | -20.56 Mn |
| Dec 31, 2022 | -39.26 Mn |
| Sep 30, 2022 | -17.29 Mn |
| Jun 30, 2022 | -23.04 Mn |
| Mar 31, 2022 | -16.62 Mn |
| Dec 31, 2021 | -13.65 Mn |
| Sep 30, 2021 | -24.03 Mn |
| Jun 30, 2021 | -31.09 Mn |